FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely, ophthalmology, and is intended to suppress the adsorption of pranoprofen and/or its pharmaceutically acceptable salt on soft contact lenses containing zwitterionic material. Ophthalmic composition for soft contact lenses containing zwitterionic material includes pranoprofen and/or a pharmaceutically acceptable salt thereof and trometamol. pH of said composition is 5.5 or higher. Also, methods are provided for suppressing the adsorption of pranoprofen and/or a pharmaceutically acceptable salt thereof on soft contact lenses containing zwitterionic material and the use of said composition.
EFFECT: use of the group of inventions makes it possible to obtain a transparent appearance of the composition by adjusting the pH to 5.5 or more and effectively suppress the adsorption of pranoprofen and/or its salt on soft contact lenses containing the zwitterionic material.
8 cl, 3 tbl, 3 ex
Authors
Dates
2018-10-12—Published
2014-05-27—Filed